Analytical Quality by Design in Stress Testing or Stability - Indicating Method

Analytical methods are required to be developed at different stages of the pharmaceutical product life cycle. The concept of QbD can be extended to analytical method development known as analytical quality by design (AQbD). Quality by design is a systematic approach to development that begins with p...

Full description

Saved in:
Bibliographic Details
Published inAsian Journal of Pharmaceutical Analysis Vol. 11; no. 2; pp. 170 - 178
Main Authors Vyas, Amitkumar J., Visana, Nilam M., Patel, Ajay I., Patel, Ashok B., Patel, Nilesh K., Shah, Sunny R.
Format Journal Article
LanguageEnglish
Published Raipur Athena Information Solutions Pvt. Ltd 01.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Analytical methods are required to be developed at different stages of the pharmaceutical product life cycle. The concept of QbD can be extended to analytical method development known as analytical quality by design (AQbD). Quality by design is a systematic approach to development that begins with predefined objects and emphasizes product and process understanding and helps in the systematic approach to drug development. The concepts described in ICH Q8- Q11, commonly referred to as quality by design (QbD), have also been applied to the development of analytical methods. The benefits of applying the QbD principle to analytical methods include identifying and minimizing sources of variability that may lead to poor method robustness and ensuring that the method meets its intended performance requirements throughout the product and method lifecycle. Stress testing is a very important tool in pharmaceutical research and development to predict long-term stability. Stress studies should be performed in stability-indicating method development to understand drug behavior but also can be performed with method validation for regulatory filling predict stability and measure impurities. For determination of degradation pathways and structural elucidation of degradation produced, these stress testing are helpful. It is also used to select the storage condition and improve the manufacturing process of formulations.
AbstractList Analytical methods are required to be developed at different stages of the pharmaceutical product life cycle. The concept of QbD can be extended to analytical method development known as analytical quality by design (AQbD). Quality by design is a systematic approach to development that begins with predefined objects and emphasizes product and process understanding and helps in the systematic approach to drug development. The concepts described in ICH Q8- Q11, commonly referred to as quality by design (QbD), have also been applied to the development of analytical methods. The benefits of applying the QbD principle to analytical methods include identifying and minimizing sources of variability that may lead to poor method robustness and ensuring that the method meets its intended performance requirements throughout the product and method lifecycle. Stress testing is a very important tool in pharmaceutical research and development to predict long-term stability. Stress studies should be performed in stability-indicating method development to understand drug behavior but also can be performed with method validation for regulatory filling predict stability and measure impurities. For determination of degradation pathways and structural elucidation of degradation produced, these stress testing are helpful. It is also used to select the storage condition and improve the manufacturing process of formulations.
According to ICH Q8 guidelines, QbD can be defined as “A Systematic approach for development that begins with predefined objectives and emphasizes the product and process understanding as well as process control, based on sound science and quality risk management. [...]changes in method failure during movement are always high. [...]the performance variable is not fully explored and knowledge. [...]the below the comparison of traditional and AQbD approaches. PART-A framework for innovative pharmaceutical development, manufacturing, and quality assurance Sep 2004 USFDA Pharmaceutical cGMP for the 21st century-A risk-based approach: final report Sep 2004 EMA The European medicines agency road map to 2010: preparing the ground for the future March 2005 ICH Pharmaceutical development (Q8) Nov 2005 ICH Quality risk management (Q9) Nov 2005 ICH Pharmaceutical quality system (Q10) June 2008 ICH Pharmaceutical development (Q8(R2)) Aug 2009 WHO Quality risk management Aug 2010 EMA Road map to 2015 Dec 2010 USFDA Guidance for industry: process validation: general principles and practices Jan 2011 EMA-USFDA EMA-FDA pilot program for parallel assessment of quality by design applications March 2011 ICH ICH- An endorsed guide for ICH Q8/Q9/Q10 Implementation Dec 2011 EMA ICH Quality IWG points to consider for ICH Q8/Q9/Q10 Guidelines Feb 2012 EMA Guidelines on real-time release testing (formerly guideline on parametric release) March 2012 EMA Guideline on process validation (draft) March 2012 USFDA Quality by design for ANDAs: an example for immediate- release dosage forms April 2012 ICH Development and manufacturing of drug substances (chemical entities and biotechnological/biological entities) (Q11) May 2012 EMA- US- FDA EMA- FDA pilot program for parallel assessment of quality-by-design application: lessons learned and QandA resulting from the first parallel assessment Aug 2013 EMA Guidelines on process validation for finished products – information and data to be provided in regulatory submission Feb 2014 1.4 Regulatory guidelines analytical QbD: Historically, designing or building the quality into products had been a necessity for complex manufacturing operations, like, aircraft manufacturing.
Author Vyas, Amitkumar J.
Patel, Nilesh K.
Shah, Sunny R.
Patel, Ajay I.
Visana, Nilam M.
Patel, Ashok B.
Author_xml – sequence: 1
  givenname: Amitkumar J.
  surname: Vyas
  fullname: Vyas, Amitkumar J.
  organization: 1Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India
– sequence: 2
  givenname: Nilam M.
  surname: Visana
  fullname: Visana, Nilam M.
  organization: Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India
– sequence: 3
  givenname: Ajay I.
  surname: Patel
  fullname: Patel, Ajay I.
  organization: Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India
– sequence: 4
  givenname: Ashok B.
  surname: Patel
  fullname: Patel, Ashok B.
  organization: Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India
– sequence: 5
  givenname: Nilesh K.
  surname: Patel
  fullname: Patel, Nilesh K.
  organization: Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India
– sequence: 6
  givenname: Sunny R.
  surname: Shah
  fullname: Shah, Sunny R.
  organization: Pharmaceutical Department, B. K. Mody Government Pharmacy Collage, Rajkot, Gujarat, India
BookMark eNo9kN1KAzEQhYMoWGsfQQh4vTWZNOnuZal_hUoR63VIskmNrNmabC_27U23UhiY4cyZYea7QZehDRahO0qmHOaUPgAwWnAx51MgQKeEEKgu0OgsX55rMb9Gk5S8JjMhKKk4HaHNIqim77xRDX4_qMZ3PdY9frTJ7wL2AX900aaEtzZ1PuxwG7OitB-MBV6FOo8OnTfbfbX1Lbpyqkl28p_H6PP5abt8Ldabl9VysS4MBVEWtLa1YQqItkxYcCpHRUildA3KgTZQauZK45wBA7qytRasKksyYxV3JWdjdH_au4_t7yEfJ7_bQ8y_JAmcMz4j2Z1d_OQysU0pWif30f-o2EtK5IBPHtnIIyd5xCcHfOwPTOJkNw
CitedBy_id crossref_primary_10_3390_pharmaceutics15102371
crossref_primary_10_18596_jotcsa_1288000
crossref_primary_10_52711_0974_360X_2024_00153
crossref_primary_10_52711_0974_360X_2024_00263
crossref_primary_10_52711_2231_5675_2023_00019
crossref_primary_10_52711_2231_5691_2022_00048
crossref_primary_10_37285_ijpsn_2023_16_2_4
crossref_primary_10_37285_ijpsn_2023_16_4_4
crossref_primary_10_52711_0974_360X_2023_00847
crossref_primary_10_52711_0974_360X_2023_00647
crossref_primary_10_52711_0974_360X_2023_00942
crossref_primary_10_52711_0974_360X_2022_00697
crossref_primary_10_1002_masy_202300142
crossref_primary_10_52711_2231_5675_2023_00022
Cites_doi 10.5958/2231-5675.2019.00021.8
10.1016/j.jpha.2013.09.003
10.4103/2230-973X.187350
10.21276/irjps.2020.7.2.4
10.2478/amma-2019-0010
10.15406/japlr.2016.03.00073
10.1155/2015/868727
10.5958/0974-360x.2017.00223.2
10.23880/oajpr-16000140
10.26717/BJSTR.2017.01.000484
10.5958/0974-360X.2017.00567.4
10.5958/2231-5675.2020.00029.0
10.7897/2230-8407.04517
10.5958/0975-4377.2019.00039.9
10.5958/2231-5659.2016.00007.2
10.5958/2231-5659.2017.00030.3
10.18231/2394-2797.2018.0001
10.1016/B978-0-12-375680-0.00003-6
10.5958/2231-5675.2016.00019.3
10.1201/9780849359194
ContentType Journal Article
Copyright Copyright 2021 A & V Publication, distributed by Contify.com
Copyright_xml – notice: Copyright 2021 A & V Publication, distributed by Contify.com
DBID AAYXX
CITATION
3V.
7X7
7XB
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PQEST
PQQKQ
PQUKI
PRINS
DOI 10.52711/2231-5675.2021.00029
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DatabaseTitle CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList CrossRef
ProQuest One Academic Eastern Edition
Database_xml – sequence: 1
  dbid: 7X7
  name: Health & Medical Collection (Proquest)
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 2231-5675
EndPage 178
ExternalDocumentID 10_52711_2231_5675_2021_00029
GeographicLocations United States--US
India
GeographicLocations_xml – name: United States--US
– name: India
GroupedDBID 7UP
7X7
8AO
8FI
8FJ
AAYXX
ABUWG
ADBBV
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
FYUFA
HMCUK
PQQKQ
UKHRP
3V.
7XB
8FK
K9.
PQEST
PQUKI
PRINS
ID FETCH-LOGICAL-c1268-1dedc3a20be36e2fa2fa9009abd2af2bc28b3f8cffc2c2b9edb6398804395f853
IEDL.DBID BENPR
ISSN 2231-5667
IngestDate Thu Oct 10 16:26:32 EDT 2024
Fri Aug 23 03:41:34 EDT 2024
IsPeerReviewed false
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1268-1dedc3a20be36e2fa2fa9009abd2af2bc28b3f8cffc2c2b9edb6398804395f853
PQID 2553540988
PQPubID 2044948
PageCount 9
ParticipantIDs proquest_journals_2553540988
crossref_primary_10_52711_2231_5675_2021_00029
PublicationCentury 2000
PublicationDate 20210601
PublicationDateYYYYMMDD 2021-06-01
PublicationDate_xml – month: 06
  year: 2021
  text: 20210601
  day: 01
PublicationDecade 2020
PublicationPlace Raipur
PublicationPlace_xml – name: Raipur
PublicationTitle Asian Journal of Pharmaceutical Analysis
PublicationYear 2021
Publisher Athena Information Solutions Pvt. Ltd
Publisher_xml – name: Athena Information Solutions Pvt. Ltd
References ref13
ref35
ref12
ref34
ref15
ref37
ref14
ref36
ref31
ref30
ref11
ref33
ref10
ref32
ref0
ref2
ref1
ref17
ref39
ref16
ref38
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref8
  doi: 10.5958/2231-5675.2019.00021.8
– ident: ref39
– ident: ref3
– ident: ref26
  doi: 10.1016/j.jpha.2013.09.003
– ident: ref7
– ident: ref17
  doi: 10.4103/2230-973X.187350
– ident: ref0
  doi: 10.21276/irjps.2020.7.2.4
– ident: ref29
– ident: ref37
  doi: 10.2478/amma-2019-0010
– ident: ref24
– ident: ref34
  doi: 10.15406/japlr.2016.03.00073
– ident: ref22
– ident: ref25
– ident: ref18
  doi: 10.1155/2015/868727
– ident: ref27
– ident: ref5
  doi: 10.5958/0974-360x.2017.00223.2
– ident: ref32
– ident: ref20
  doi: 10.23880/oajpr-16000140
– ident: ref15
– ident: ref9
  doi: 10.26717/BJSTR.2017.01.000484
– ident: ref11
  doi: 10.5958/0974-360X.2017.00567.4
– ident: ref30
– ident: ref13
– ident: ref1
  doi: 10.5958/2231-5675.2020.00029.0
– ident: ref36
– ident: ref2
– ident: ref12
  doi: 10.1155/2015/868727
– ident: ref31
  doi: 10.7897/2230-8407.04517
– ident: ref38
  doi: 10.5958/0975-4377.2019.00039.9
– ident: ref14
  doi: 10.5958/2231-5659.2016.00007.2
– ident: ref28
– ident: ref16
  doi: 10.5958/2231-5659.2017.00030.3
– ident: ref21
– ident: ref4
  doi: 10.18231/2394-2797.2018.0001
– ident: ref23
– ident: ref33
  doi: 10.1016/B978-0-12-375680-0.00003-6
– ident: ref6
  doi: 10.5958/2231-5675.2016.00019.3
– ident: ref19
  doi: 10.1201/9780849359194
– ident: ref10
– ident: ref35
SSID ssib046610951
ssib041264454
ssj0002964730
Score 2.2009544
Snippet Analytical methods are required to be developed at different stages of the pharmaceutical product life cycle. The concept of QbD can be extended to analytical...
According to ICH Q8 guidelines, QbD can be defined as “A Systematic approach for development that begins with predefined objectives and emphasizes the product...
SourceID proquest
crossref
SourceType Aggregation Database
StartPage 170
SubjectTerms 21st century
Chromatography
Drug dosages
Manufacturing
Methods
Pharmaceutical industry
Pharmaceuticals
Pharmacy
Principles
Process controls
Product development
Product life cycle
Quality control
Reproducibility
Variables
Title Analytical Quality by Design in Stress Testing or Stability - Indicating Method
URI https://www.proquest.com/docview/2553540988
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTwIxEG4ELl6MRo0okh68Fmj32ZPxAUET0Cgk3Jq-1nhZEPDAv3fa7YZwMdlTm91kv7bzfTNtZxC6K4BWlOKaKC4liUHwE27cugJyi4zJFcvdReHJNB3P49dFsggBt004VlnbRG-ozVK7GHkfpK8LUfA8v1_9EFc1yu2uhhIaDdRi4CmwJmo9DqfvH_WMiqnj-z1hxqnLLh72wZytdpuOmS9IAjRJCWibrLrmk7CM0n5ozBJwJBnt-RcOCezQfntSGp2ik6Am8UM1_GfoyJbn6M0nGvExalylyNhhtcPP_qwG_i7xp78fgmcuwUb5hZdraKnSde8wwS-l8XE86Jn48tIXaD4azp7GJNRNIBr-F5xCY42OJBsoG6WWFRIeDlpKKsNkwZRmuYqKXBeFZpopbo0CnQILGcRJUgB_X6JmuSztFcIDqVNJI02tBvAjDfqBy1hqZtNMSpq2Ua8GQ6yq9BgC3AqPnnDoCYeecOgJj14bdWrIRFgtG7Ef2-v_u2_QsftUdVSrg5rb9a-9BVGwVV3UyBZZN4z_HzcCsL8
link.rule.ids 315,783,787,12070,21402,27938,27939,31733,33758,43324,43819
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NTwIxEG0UD3oxGjWiqD14LdDush8nY1QCCngQEm5Nv9Z4WRDwwL93plskXEz21M1usq_bea_T9g0h9wXQita5YTpXisUg-FlucVwBuUXWZlpkeFB4OEp6k_h12pmGhNsybKvcxEQfqO3MYI68BdIXUxR5lj3MvxlWjcLV1VBCY58coA8Xeuen0z86jTmy_ZYu4wS9xcMqGEZqXHJMfTkSIEnOQNmk1SGfjkg5b4XGtAPTSMGb_oFd-tqN3p6SuifkOGhJ-lh1_inZc-UZefc2Iz5DTSuDjDXVa_rsd2rQr5J--NMhdIz2GuUnnS2gpTLrXlNG-6X1WTy4M_TFpc_JpPsyfuqxUDWBGfhemBJaZ02kRFu7KHGiUHDloKSUtkIVQhuR6ajITFEYYYTOndWgUmAYgzTpFMDeF6RWzkp3SWhbmUTxyHBnAPrIgHrIVayMcEmqFE_qpLkBQ84rcwwJkwqPnkT0JKInET3p0auTxgYyGcbKUm579ur_23fksDceDuSgP3q7Jkf42mrTVoPUVosfdwPyYKVv_T_wC2s2sWM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analytical+Quality+by+Design+in+Stress+Testing+or+Stability+-+Indicating+Method&rft.jtitle=Asian+Journal+of+Pharmaceutical+Analysis&rft.au=Vya%2C+Amitkumar+J&rft.au=Visana%2C+Nilam+M&rft.au=Patel%2C+Ajay+I&rft.au=Patel%2C+Ashok+B&rft.date=2021-06-01&rft.pub=Athena+Information+Solutions+Pvt.+Ltd&rft.issn=2231-5667&rft.eissn=2231-5675&rft.volume=11&rft.issue=2&rft_id=info:doi/10.52711%2F2231-5675.2021.00029
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2231-5667&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2231-5667&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2231-5667&client=summon